• Citer

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

par Body, Jean-Jacques ;Bergmann, Pierre ;Boonen, Steven;Devogelaer, J.-P.;Gielen, E;Goemaere, Stefan;Kaufman, Jean-Marc;Rozenberg, Serge ;Reginster, Jean-Yves
Référence Osteoporosis international, 23 Suppl 1, page (S1-23)
Publication Publié, 2012-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Auteur:	Body, Jean-Jacques; Bergmann, Pierre; Boonen, Steven; Devogelaer, J.-P.; Gielen, E; Goemaere, Stefan; Kaufman, Jean-Marc; Rozenberg, Serge; Reginster, Jean-Yves
Informations sur la publication:	Osteoporosis international, 23 Suppl 1, page (S1-23)
Statut de publication:	Publié, 2012-02
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Bisphosphonate
	Calcium
	Denosumab
	Osteoporosis
	SERM
	Strontium ranelate
	Vitamin D
MeSH keywords:	Aged
	Antibodies, Monoclonal -- pharmacology
	Antibodies, Monoclonal, Humanized
	Bone Density Conservation Agents -- pharmacology -- therapeutic use
	Calcium -- pharmacology -- therapeutic use
	Cardiovascular Diseases -- chemically induced
	Consensus
	Dietary Supplements -- adverse effects
	Diphosphonates -- pharmacology -- therapeutic use
	Female
	Humans
	Male
	Middle Aged
	Muscle, Skeletal -- drug effects
	Neoplasms -- chemically induced
	Organometallic Compounds -- pharmacology
	Osteoporosis -- drug therapy
	Selective Estrogen Receptor Modulators -- pharmacology -- therapeutic use
	Stroke -- chemically induced
	Thiophenes -- pharmacology
	Vitamin D -- pharmacology -- therapeutic use
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0937-941X
	info:doi/10.1007/s00198-011-1891-8
	info:scp/84857302591
	info:pmid/22311111
	PMC3273686